FDA Pushes Pause on 2 Regeneron Lymphoma Trials for Cytokine Release Syndrome,

The U.S. Food and Drug Administration (FDA) placed a partial clinical hold on the trials, requesting Regeneron modify protocols to decrease the …, The U.S. Food and Drug Administration (FDA) placed a partial clinical hold on the trials, requesting Regeneron modify protocols to decrease the …, Read More

Scroll to Top